4 hrs ago
Press Digest - Wall Street Journal - July 31
The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Wed Jul 30, 2014
Hologic's (HOLX) CEO Stephen MacMillan on Q3 2014 Results - Earnings Call Transcript
Good afternoon, everyone, and welcome to the Hologic, Inc. Third Quarter Fiscal 2014 Earnings Call.
J&J to call for voluntary return of morcellators
Johnson & Johnson, which already suspended sales of a surgical tool that has been blamed for spreading a dangerous cancer in women, now plans to tell doctors world-wide to return any devices currently on shelves.
Tue Jul 29, 2014
U.S. Senate panel to look into price setting for contact lenses
Moves by three of the four major U.S. contact lens makers to set price floors for many of their products, preventing low-cost retailers from discounting the expensive devices, have drawn scrutiny from lawmakers.
Mon Jul 28, 2014
Press release distribution, EDGAR filing, XBRL, regulatory filings
Dat maakte OCD ... )--Research and Markets has announced the addition of the "Global AC Drives Market 2014-2018" report to th... )--Research and Markets has announced the addition of the "Global Market Report of Diisobutylcarbinol" report... )--Cleversafe, Inc., the industry leading object-based storage provider, today announced that Peter Howard ... (more)
Ortho-Clinical Diagnostics, Inc. Signs Agreement with Astute Medical, ...
The NEPHROCHECK Test and ASTUTE140 Meter are used in a hospital setting to assess critically-ill patients for risk of acute kidney injury , an increasing burden worldwide that can lead to poor patient outcomes and increased healthcare expenditures if not detected at an early stage.
Fri Jul 25, 2014
Xarelto Side Effects Lawsuit News: New Lawsuit Alleges Xarelto...
Close to 10 Xarelto side effects lawsuits have been filed in the United States against Janssen Pharmaceuticals, a division of Johnson & Johnson and Germany-based Bayer AG over its blood-thinning medication.
Tue Jul 22, 2014
The Motley Fool
3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Here are three quotes from the call and some commentary about why they're so important.
Mon Jul 21, 2014
Daily Dividend Report: JNJ, HAL, AGN, APD, SPN, ZION, BRO
Johnson & Johnson has declared a cash dividend for the third quarter of 2014 of $0.70 per share on the company's common stock.
Sun Jul 20, 2014
The Jersey Journal
Work in progress: Johnson & Johnson 'outsider' helps revive recall-plagued consumer unit
To fix Johnson & Johnson's disgraced consumer unit, Sandra Peterson took a gamble, jettisoning several well-known brands, including K-Y Jelly, to concentrate on big sellers such as the pain pill Tylenol.
Fri Jul 18, 2014
Johnson & Johnson inspires caring in children with 'Once Upon A Care'
A good value system is essential when raising a child. You want your child to grow up to be kind, caring and compassionate to everyone who enters their life whether a family member or a stranger.
Wed Jul 16, 2014
Johnson & Johnson (JNJ) CEO Talks About Turn Around In Their Consumer Segment Business
Drug major Johnson & Johnson Chairman of the Board, Chief Executive Officer Alex Gorsky in a wide ranging interview with Carol Massar of Bloomberg TV on its "Bloomberg West" program shared his firm's road map to grow the business over the next few years via strategic acquisitions and his plans to streamline operations by going in for divestures to ... (more)
Tue Jul 15, 2014
Dow-30 Earnings: Johnson & Johnson
Value Line is regarded as the best independent research available. More than just recommendations, Value Line provides the rationale behind its picks for greater understanding.
Stock futures edge up following mixed retail data
Stock futures edged higher Tuesday as investors digested mixed U.S. retail sales data and several corporate earnings reports.
Silver City Sun-News
J&J 2Q profit climbs 13 percent
Johnson & Johnson on Tuesday reported earnings that climbed by 13 percent in its second quarter, and topped analysts' expectations.
Sun Jul 13, 2014
Johnson & Johnson Prescribes Healthy Returns Without M&A or Breakup
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Fri Jul 11, 2014
USHCC Applauds Johnson & Johnson for Joining President Obama's Supply Chain Initiative
The United States Hispanic Chamber of Commerce applauds Johnson & Johnson, a leading global healthcare products and services company, for joining President Obama's initiative to support small businesses by expediting the payment process to supply chain providers.
Johnson & Johnson Earnings Should Show Pharma Buisness To Remain Strong
Johnson & Johnson will report its Q2 2014 earnings on July 15. We expect no significant change in the intensity of the main trends driving the company's business .
Law Firm Newswire
New Jersey Court Transfers Ethicon Abdominal Mesh Lawsuits to...
New Jersey's Atlantic County Superior Court has been the site of a multicounty litigation that consolidated thousands of transvaginal mesh lawsuits that have been brought by women alleging injuries caused by Ethicon transvaginal mesh devices .
Thu Jul 10, 2014
Settlement Over Deceptive Implant Marketing
Johnson & Johnson has reached a four million settlement with the state of Oregon to resolve allegations that J&J improperly marketed its DePuy ASR metal-on-metal hip implants.